What is Noveltreat 1 mg Pre-filled Pen

Noveltreat 1 mg Pre-filled Pen is a once-weekly injectable medication designed to support weight management in adults with Obesity or those who are overweight with weight-related health conditions such as cardiovascular disease. Each box contains 2 pre-filled pens for convenient administration. Sun Pharmaceuticals manufactures Noveltreat 1 mg pen in GMP-compliant facilities.

This medicine contains FDA-approved Semaglutide base (1 mg/0.5 ml), a Glucagon-like Peptide-1 (GLP-1) receptor agonist that mimics natural hormones in the body. Semaglutide slows gastric emptying and controls appetite, which leads to decreased calorie intake and gradual weight loss. It helps regulate blood sugar levels by leading to insulin release when glucose levels are elevated.

The starting dose of Semaglutide is 0.25 mg once weekly for the first four weeks, gradually increasing to 1 mg weekly as the body adjusts to the medication. The injection should be administered under the skin in the thigh, abdomen, or upper arm on the same day each week. Treatment effectiveness is enhanced when combined with a reduced-calorie diet and increased physical activity.

Common side effects of Noveltreat 1 mg include nausea, vomiting, diarrhea, constipation, and abdominal discomfort, which typically diminish as your body adapts to the medication. Before starting Noveltreat, inform the doctor about any history of Pancreatitis, thyroid disorders, or kidney problems.

Store Noveltreat 1 mg Pre-filled Pen in the refrigerator between 2°C-8°C before first use. After initial use, it can be stored at room temperature below 30°C or refrigerated for up to 6 weeks. Keep the pen cap on when not in use to protect from light, and dispose of used pens properly in a sharps container.

What are the benefits of taking Noveltreat 1 mg Pre-filled Pen

Noveltreat 1 mg Pre-filled Pen offers significant benefits for people struggling with weight management and metabolic health. Some of them include:

• Effective weight reduction: Semaglutide helps achieve substantial weight loss by reducing appetite and increasing the feeling of fullness.
• Blood sugar control: It helps manage glucose levels, making it effective for those with Type 2 Diabetes or prediabetes.
• Cardiovascular benefits: Clinical studies show reduced risk of major cardiovascular events in people with existing heart disease.
• Improved metabolic health: Treatment leads to better cholesterol levels, reduced blood pressure, and overall enhancement of metabolic markers.

How to use Noveltreat 1 mg Pre-filled Pen

Noveltreat 1 mg Pre-filled Pen is a prescription medicine that should be used under medical supervision. Follow these guidelines for proper administration:

• Inject Noveltreat once weekly on the same day each week, at any time of day, with or without meals.
• Administer the injection subcutaneously (under the skin) into the abdomen, thigh, or upper arm after cleaning the area with an alcohol swab. Rotate injection sites with each dose to prevent skin irritation and ensure consistent absorption.
• It can be taken with or without food. However, consuming light meals can prevent nausea.
• Never exceed the prescribed dosage or take more than one injection per week.

Strengths and Substitutes

Noveltreat Pre-filled Pen is currently available in a single strength at Cheap Medicine Shop. However, the following effective alternatives are available:

View all substitutes

What are the side effects of Noveltreat 1 mg Pre-filled Pen

Like any medication, Noveltreat 1 mg Pre-filled Pen can cause side effects that are mostly mild and temporary as the body adjusts. Some of them include:

• Nausea or vomiting
• Diarrhea or constipation
• Abdominal pain or discomfort
• Decreased appetite
• Headache
• Fatigue or dizziness
• Injection site reactions

If any of these effects persist or worsen, seek medical help immediately.

Safety Advice

Liver Disease

Patients with liver disease should use Noveltreat 1 mg with caution. Also, inform the healthcare provider about any liver conditions. Regular monitoring may be recommended for those with significant liver dysfunction.

Kidney Impairment

Noveltreat should be used with caution in the case of kidney impairment, particularly in those with severe renal disease. While dose adjustment may not be necessary for mild to moderate kidney dysfunction, gastrointestinal side effects like nausea can lead to dehydration, potentially worsening kidney function. Regular monitoring and adequate hydration are essential during treatment.

Pregnant and Breastfeeding women

Semaglutide injection is not recommended during pregnancy, as it can harm the developing fetus. Discontinue the medication at least 2 months before a planned pregnancy. It is unknown whether Semaglutide passes into breast milk, so breastfeeding women should consult a healthcare provider to weigh potential risks and benefits before use.

Avoid

Do not use Noveltreat in case of a history of Medullary Thyroid Carcinoma (cancer of the thyroid gland) or Multiple Endocrine Neoplasia Syndrome Type 2 (tumor of the endocrine gland) and Type 1 Diabetes. Avoid this medication if allergic to Semaglutide. Avoid alcohol use as it can increase the possibility of low blood sugar and worsen gastrointestinal side effects.